查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1924729

外周支撐導管導引線市場按類型、材質、塗層、尖端、應用和最終用戶分類 - 全球預測 2026-2032

Peripheral Supportive Guide Wire Market by Type, Material, Coating, Tip Configuration, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年外周支撐導管導引線市場價值為 5.6677 億美元，預計到 2026 年將成長至 6.3361 億美元，預計到 2032 年將達到 12.6271 億美元，複合年成長率為 12.12%。

關鍵市場統計數據
基準年 2025 5.6677億美元
預計年份：2026年 6.3361億美元
預測年份 2032 12.6271億美元
複合年成長率 (%) 12.12%

對影響現代血管內手術中周邊導管導引線使用的技術、臨床和商業性環境進行權威深入的剖析。

周邊血管支撐導管導引線已發展成為日益廣泛的血管內手術中不可或缺的組成部分，是器械輸送、病變穿刺和治療性介入的基礎通道。這些器械融合了機械性能、材料科學和先進設計，以滿足心血管、神經血管和周邊介入治療中多樣化的臨床需求。臨床醫生優先考慮易用性、觸覺回饋和非侵入性，而醫院採購部門和門診中心則考慮滅菌相容性、供應連續性和生命週期成本。

臨床預期、材料創新和供應鏈永續性的融合如何重塑導管導引線研發的產品策略和競爭優勢

由於臨床需求、材料創新和醫療服務體系重組的融合，周邊血管支撐導管導引線的市場格局正在轉變。微創手術需求的不斷成長，使得導絲的操控性和扭矩傳遞性能備受重視，促使研發人員不斷改進導絲核心設計，並開發多樣化的尖端幾何形狀，以應對複雜的血管解剖結構。同時，混合手術和影像引導介入的興起，也提升了在多種影像模式下均能展現可預測性能的導絲的價值。

對 2025 年關稅調整如何改變導管導引線產業的到岸成本、籌資策略、購買行為和供應商韌性進行全面評估。

2025年的關稅調整和貿易政策轉變對外圍支撐導管導引線系統產生了累積影響，導致到岸成本上升、採購管道變更以及供應商多元化進程加快。擁有全球製造地的製造商正在重新評估其零件採購，最佳化材料清單結構以降低關稅風險，並整合供應商關係以確保交貨可靠性。這些措施也促使原始設備製造商 (OEM) 和契約製造製造商之間就長期產能和成本分攤機制展開活性化談判。

利用多層次細分框架，將臨床應用、設備類型、材料、塗層、先進結構和最終用戶工作流程連結起來，制定精準的產品和商業策略。

細分市場分析揭示了不同的效能預期和應用路徑，這些都為產品設計和市場推廣策略提供了基礎。依應用領域分類，導管導引線市場涵蓋心血管、神經血管和周邊血管領域，其中心血管領域可進一步細分為冠狀動脈介入治療和周邊心血管手術。神經血管應用領域則因動脈瘤栓塞和中風介入治療的需求而有所差異，而周邊血管應用領域則包括頸動脈、下肢和腎血管介入治療。這些臨床應用領域對導絲尖端柔軟性、推送性和扭矩控制等屬性提出了不同的要求，因此難以採用「一刀切」的策略來滿足所有手術領域的臨床需求。

美洲、歐洲、中東和非洲以及亞太地區的臨床實踐、監管差異和供應鏈現狀將如何決定不同的商業化和推廣路徑？

區域趨勢對關鍵地區的市場進入、臨床合作和供應鏈發展提出了不同的要求。在美洲，心血管和周邊介入手術量龐大，大型醫院系統實力雄厚，競爭格局以差異化的臨床結果和服務模式為核心，這些因素共同塑造了採購趨勢。因此，供應商往往優先考慮參與臨床試驗和獲得醫院外科醫生的支持，以推動產品應用。

競爭定位和能力叢集評估重點關注臨床差異化、材料技術領先地位以及供應鏈策略，這些因素共同推動了導管導引線產品系列的持續領先地位。

導管導引線領域的競爭格局正在發生變化，老牌醫療設備製造商和新興專業公司在臨床差異化、材料科學技術和供應可靠性方面競爭。擁有整合研發能力和臨床支援計畫的公司在產生醫院廣泛採用所需的臨床證據方面具有優勢。同時，提供客製化培訓、快速回應的技術支援以及符合醫院庫存管理實務的供應協議的製造商，能夠加強與終端用戶的長期合作關係。

整合材料創新、臨床證據、供應鏈韌性和商業模式的實用策略重點，以在不同的醫療保健服務環境中實現持續的偏好。

產業領導者應採取多管齊下的策略，整合產品創新、臨床證據產生和穩健的供應鏈。首先，應優先開發平台，其設計特性應直接滿足上述差異化的臨床需求，並確保材料選擇、塗層化學性質和尖端幾何形狀均通過針對特定手術的台架測試和臨床醫生主導的可用性研究檢驗。其次，需要投資於有針對性的臨床項目，以證明手術效率、安全性結果以及與配套器械整合的益處。這些計畫應透過同儕審查的臨床論壇進行推廣，並與產業領導者合作。

採用嚴謹的混合方法調查方法，結合臨床醫生訪談、監管審查、供應鏈分析和證據綜合，以獲得可操作的醫療器材和商業性洞察。

我們的研究途徑結合了定性和定量方法，旨在獲得具有臨床意義和可操作性的見解。我們透過對介入性心臟病專家、介入神經放射學、血管外科醫生、採購主管和供應鏈主管進行結構化訪談，收集了關鍵資訊，以獲取關於設備性能、採購因素和臨床工作流程整合的第一手意見。此外，我們也諮詢了監管和滅菌專家，以補充這些訪談，以便更好地理解開發和合規方面的考量。

一項全面的分析，旨在明確在醫療保健機構中實現持續應用所需的技術、臨床和營運方面的必要條件。

累積分析表明，外周支撐導管導引線領域的成功取決於將設備特性與特定臨床應用緊密匹配，同時建立穩健的商業和供應模式。材料和塗層創新、精密的尖端幾何形狀以及針對特定手術的檢驗是臨床應用的核心，但這些技術優勢必須與採購部門和臨床管理團隊所重視的、可證明的營運效益相結合。區域市場動態要求採取適應性策略，充分考慮不同的法規結構、醫院類型和臨床醫生培訓路徑。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 外周支撐導管導引線市場（按類型分類）

  • 親水性
  • 非親水性

9. 外周支撐導管導引線市場（依材質分類）

  • 鎳鈦諾
  • 不銹鋼

10. 外周支撐導管導引線市場（依塗層分類）

  • 親水性
  • PTFE
  • 矽酮

第11章 依尖端形狀分類的外周支撐導管導引線市場

  • 角度
  • J形尖端
  • 直的

第12章 外圍支撐導管導引線市場（依應用領域分類）

  • 心血管系統
    • 冠狀動脈
    • 周邊心血管系統
  • 神經血管
    • 動脈瘤栓塞術
    • 中風治療
  • 周邊血管
    • 頸動脈血管
    • 下肢
    • 腎臟血管

第13章 外圍支撐導管導引線市場（依最終用戶分類）

  • 門診手術中心
    • 循環系統中心
    • 周邊血管中心
  • 醫院
  • 專科診所

14. 周邊支撐導管導引線市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 周邊支撐導管導引線市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國外周支撐導管導引線市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

17. 美國周邊設備支援導管導引線市場

第18章：中國周邊支撐導管導引線市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Cordis Corporation
  • Galt Medical Corp.
  • Integer Holdings Corporation
  • Medtronic plc
  • Meril Life Sciences Private Limited
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • MicroVention, Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Vascular Solutions, Inc.
Product Code: MRR-7A380DA7C45B

The Peripheral Supportive Guide Wire Market was valued at USD 566.77 million in 2025 and is projected to grow to USD 633.61 million in 2026, with a CAGR of 12.12%, reaching USD 1,262.71 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 566.77 million
Estimated Year [2026] USD 633.61 million
Forecast Year [2032] USD 1,262.71 million
CAGR (%) 12.12%

An authoritative orientation to the technological, clinical, and commercial landscape shaping peripheral supportive guide wire use across contemporary endovascular practice

Peripheral supportive guide wires have evolved into indispensable components across a growing range of endovascular procedures, serving as the foundational conduit for device delivery, lesion crossing, and therapeutic intervention. These devices combine mechanical performance, material science, and tip engineering to meet diverse clinical demands in cardiovascular, neurovascular, and peripheral vascular interventions. Clinicians prioritize navigability, tactile feedback, and atraumatic behavior, while hospital procurement and ambulatory centers weigh sterilization compatibility, supply continuity, and lifecycle costs.

Over the past decade, iterative improvements in nitinol metallurgy, coating chemistry, and tip configurations have enabled clinicians to address increasingly complex anatomies with confidence. As procedural volumes rise and interventional techniques diversify, guide wires have become central to multidisciplinary pathways that span coronary revascularization, cerebrovascular interventions, and lower-extremity revascularization. Consequently, product development has shifted toward purpose-driven portfolios that emphasize specific clinical applications, end-user workflows, and compatibility with emerging catheter and device platforms.

Transitioning from legacy stainless steel constructions to more advanced materials has broadened the performance envelope, while regulatory scrutiny and reimbursement dynamics continue to shape adoption timelines. In this context, stakeholders require concise, clinically grounded intelligence to prioritize R&D investment, refine supply chain strategies, and align commercialization efforts with evolving procedural standards.

How converging clinical expectations, material innovation, and supply resilience are reshaping product strategy and competitive advantage in guide wire development

The landscape for peripheral supportive guide wires is undergoing transformative shifts driven by converging clinical demands, material innovation, and care delivery reconfiguration. Minimally invasive expectations have increased the premium on enhanced steerability and torque transmission, prompting developers to refine core design attributes and expand tip geometries to match complex vessel anatomies. In parallel, the diffusion of hybrid procedures and the rise of image-guided interventions have increased the value of wires that offer predictable behavior under diverse imaging modalities.

Supply chain restructuring and nearshoring trends have influenced sourcing strategies for raw materials such as nitinol and specialty coatings, elevating resilience as a board-level priority. Regulatory pathways have also become more exacting, with increased emphasis on biocompatibility and sterilization validation that affect development timelines. Clinician preferences are shifting as well; multidisciplinary teams now demand devices that integrate seamlessly with a growing array of catheters, sheaths, and embolic systems, which is driving tighter collaboration between device makers and clinical research networks.

Taken together, these dynamics are fostering a market environment where incremental innovation is supplemented by targeted platform strategies aimed at specific clinical subspecialties. As a result, companies that can demonstrate clear clinical differentiation, robust quality systems, and responsive supply models are positioned to capture preference among clinicians and procurement stakeholders alike.

An integrated assessment of how 2025 tariff adjustments are altering landed costs, sourcing strategies, procurement behavior, and supplier resilience across the guide wire ecosystem

Recent tariff adjustments and trade policy shifts introduced in 2025 have had a cumulative impact on the peripheral supportive guide wire ecosystem by increasing landed costs, prompting sourcing realignments, and accelerating supplier diversification. Manufacturers with global manufacturing footprints have responded by reassessing component sourcing, optimizing bill-of-materials compositions to reduce tariff exposure, and consolidating supplier relationships to preserve delivery reliability. These measures have also intensified negotiations between OEMs and contract manufacturers regarding long-term capacity commitments and cost-sharing mechanisms.

Procurement teams within hospitals and ambulatory surgical centers are adapting by expanding supplier qualification protocols and by seeking transparency around total cost of ownership rather than unit price alone. In addition, distributors and group purchasing organizations have adjusted inventory policies to mitigate short-term volatility, emphasizing buffer stocks for high-use items while collaborating on logistic efficiencies.

Clinically, the ripple effects have been more operational than procedural; where hospitals face higher acquisition costs, prioritization frameworks have shifted toward devices that deliver demonstrable procedural efficiencies or reduce downstream resource consumption. From a strategic perspective, companies able to evidence resilient regional supply chains, local value-add, and clear regulatory compliance have a competitive edge in negotiating long-term contracts in this new tariff environment.

A layered segmentation framework connecting clinical applications, device types, materials, coatings, tip architectures, and end-user workflows to inform precise product and commercial strategies

Segmentation intelligence reveals differentiated performance expectations and adoption pathways that inform both product design and go-to-market approaches. Based on application, the guide wire landscape spans cardiovascular, neurovascular, and peripheral vascular uses, with cardiovascular requirements further refined across coronary artery interventions and peripheral cardiovascular procedures; neurovascular applications are distinguished between aneurysm coiling and stroke intervention needs; and peripheral vascular use cases encompass carotid vascular, lower extremity, and renal vascular interventions. These clinical subdivisions impose distinct demands on attributes such as tip flexibility, pushability, and torque control, meaning that a one-size-fits-all strategy is unlikely to achieve clinical preference across all procedural domains.

Based on type, products are categorized as hydrophilic or non-hydrophilic, a classification that directly influences navigation performance, lubricity, and operator handling under various procedural conditions. Based on material, nitinol and stainless steel represent two material classes with differing trade-offs between superelasticity, memory, and radiopacity; choosing between them is a function of the targeted vessel tortuosity and clinical endpoint. Based on coating, hydrophilic, PTFE, and silicone coatings each deliver discrete surface interactions with vessel walls and catheter assemblies, shaping clinical selection for specific lesion types and imaging environments. Based on tip configuration, angled, J-tip, and straight tip designs support different crossing strategies and vessel engagement techniques, with tip choice often dictated by the lesion morphology and access strategy.

Based on end user, commercial strategies must reflect the distinct purchasing and clinical workflows of ambulatory surgical centers, hospitals, and specialty clinics. Ambulatory surgical centers include dedicated cardiovascular centers and peripheral centers that favor throughput and disposables models, while hospital segments include community hospitals and tertiary care hospitals where preference may be driven by complex-case performance and integration with advanced imaging suites. Recognizing these layered segmentations enables a granular approach to portfolio planning, clinical evidence generation, and targeted value propositions for each buyer archetype.

How regional clinical practices, regulatory nuance, and supply chain realities across the Americas, Europe Middle East & Africa, and Asia-Pacific determine differentiated commercialization and adoption pathways

Regional dynamics create distinct imperatives for market entry, clinical engagement, and supply chain architecture across major geographies. In the Americas, purchasing tendencies are shaped by high procedural volumes in advanced cardiovascular and peripheral interventions, a strong presence of large hospital systems, and a competitive supplier landscape that rewards differentiation in clinical outcomes and service models. As a consequence, vendors often prioritize clinical trial engagement and hospital-based surgeon advocacy to drive adoption.

In Europe, Middle East & Africa, variability in regulatory frameworks and heterogeneous procurement practices require adaptable market access approaches. Reimbursement nuance and national purchasing protocols create opportunities for regionally tailored product variants and localized technical support. Manufacturers that invest in regional regulatory expertise and distributor relationships can accelerate adoption by aligning product claims with jurisdictional requirements.

In Asia-Pacific, rapid expansion of interventional capacity, diverse hospital archetypes, and a growing preference for high-performance devices are reshaping demand patterns. Local manufacturing partnerships and regional clinical training programs are proving effective in building clinician trust and addressing logistical constraints. Across all regions, a common thread is the increasing emphasis on supply chain resilience, localized regulatory alignment, and clinician education to support safe and effective device utilization.

An evaluation of competitive positioning and capability clusters that highlight clinical differentiation, materials leadership, and supply chain strategies driving sustained preference in guide wire portfolios

Competitive dynamics in the guide wire segment are evolving as established device manufacturers and emerging specialized firms compete on clinical differentiation, material science expertise, and supply reliability. Companies with integrated R&D capabilities and clinical advocacy programs have an advantage in generating the procedural evidence required for broad hospital adoption. Meanwhile, manufacturers that offer tailored training, rapid technical support, and supply agreements that align with hospital inventory practices strengthen long-term relationships with end users.

In addition, specialist developers focusing on coatings chemistry, tip innovation, or niche clinical applications are influencing overall product expectations by introducing targeted solutions that address specific procedural pain points. Strategic partnerships between device makers and contract manufacturing organizations are becoming more prevalent, enabling flexible manufacturing scale-up while preserving product quality. Distribution strategies likewise vary, with some companies opting for direct hospital engagement and clinical education, and others working through regional distributors to extend reach into varied healthcare settings.

Ultimately, competitive advantage accrues to organizations that can demonstrate a clear clinical value proposition, robust quality and regulatory systems, and adaptable supply models that mitigate disruption while supporting clinician adoption and procurement requirements.

Actionable strategic priorities to align material innovation, clinical evidence, supply resilience, and commercial models for sustained preference across diverse healthcare delivery settings

Industry leaders should pursue a multi-dimensional strategy that aligns product innovation, clinical evidence generation, and resilient supply operations. First, prioritize platform development that maps design attributes directly to the segmented clinical needs described earlier, ensuring that material selection, coating chemistry, and tip configuration are validated through procedure-specific bench testing and clinician-led usability studies. Second, invest in targeted clinical programs that demonstrate procedural efficiency, safety outcomes, and integration benefits with complementary devices; these programs should be designed for dissemination through peer-reviewed clinical forums and key opinion leader engagement.

Third, strengthen supply chain resilience by diversifying qualified suppliers, exploring regional manufacturing options, and incorporating tariff exposure into procurement contracts. Fourth, align commercial models to the end-user landscape by creating differentiated value propositions for ambulatory surgical centers, community hospitals, tertiary care centers, and specialty clinics, offering tailored training, bundled service offerings, and inventory management solutions that reduce administrative burden. Fifth, accelerate regulatory readiness by building cross-functional teams that can anticipate jurisdictional requirements, streamline submission packages, and ensure post-market surveillance is both rigorous and transparent.

By executing these priorities in parallel and measuring progress through operational and clinical KPIs, organizations can both mitigate near-term headwinds and position themselves for sustained preference among clinicians and procurement stakeholders.

A rigorous mixed-methods research framework combining clinician interviews, regulatory review, supply chain mapping, and evidence synthesis to produce actionable device and commercial insights

The research approach combined qualitative and quantitative techniques to produce clinically relevant, operationally actionable insights. Primary input was gathered through structured interviews with interventional cardiologists, neurointerventional specialists, vascular surgeons, procurement leaders, and supply chain executives to capture firsthand perspectives on device performance, purchasing drivers, and clinical workflow integration. These interviews were complemented by advisory consultations with regulatory and sterilization experts to contextualize development and compliance considerations.

Secondary research included a structured review of peer-reviewed clinical literature, procedural guidelines, and publicly available regulatory documentation to validate clinical use-cases and to triangulate device attribute requirements. Supply chain mapping analyzed component sourcing, contract manufacturing relationships, and logistics pathways to identify potential points of vulnerability and resilience strategies. Finally, a synthesis phase translated technical findings into commercial implications, testing hypotheses against clinician priorities and procurement realities to ensure recommendations were both clinically credible and operationally feasible.

Throughout the process, quality controls included cross-validation of interview inputs, internal expert review of clinical inferences, and iterative refinement of conclusions to ensure clarity, relevance, and applicability for strategy and product development stakeholders.

A consolidated synthesis identifying the essential technical, clinical, and operational imperatives required to translate product capability into sustained adoption across healthcare settings

The cumulative analysis highlights that success in the peripheral supportive guide wire domain hinges on tightly aligning device attributes to specific clinical applications while simultaneously building resilient commercial and supply models. Material and coating innovations, refined tip geometries, and procedure-specific validation are central to clinical adoption, but these technical strengths must be paired with demonstrable operational benefits that matter to procurement and clinical governance teams. Regional market dynamics demand adaptive approaches that account for differing regulatory frameworks, hospital archetypes, and clinician training pathways.

Moreover, recent trade policy adjustments have underscored the need for strategic supply chain planning, encouraging manufacturers to explore regional sourcing and manufacturing partnerships to maintain competitive cost structures and secure delivery timelines. Competitive differentiation will increasingly depend on the ability to offer integrated solutions that combine performance, evidence, and service models tailored to the needs of ambulatory surgical centers, community and tertiary hospitals, and specialty clinics.

Collectively, these insights suggest a path forward for organizations seeking to convert technical capability into durable market preference: prioritize application-led design, invest in high-quality clinical validation, and build supply chains and commercial models that are both resilient and responsive to end-user needs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral Supportive Guide Wire Market, by Type

  • 8.1. Hydrophilic
  • 8.2. Non-Hydrophilic

9. Peripheral Supportive Guide Wire Market, by Material

  • 9.1. Nitinol
  • 9.2. Stainless Steel

10. Peripheral Supportive Guide Wire Market, by Coating

  • 10.1. Hydrophilic
  • 10.2. PTFE
  • 10.3. Silicone

11. Peripheral Supportive Guide Wire Market, by Tip Configuration

  • 11.1. Angled
  • 11.2. J-Tip
  • 11.3. Straight

12. Peripheral Supportive Guide Wire Market, by Application

  • 12.1. Cardiovascular
    • 12.1.1. Coronary Artery
    • 12.1.2. Peripheral Cardiovascular
  • 12.2. Neurovascular
    • 12.2.1. Aneurysm Coiling
    • 12.2.2. Stroke Intervention
  • 12.3. Peripheral Vascular
    • 12.3.1. Carotid Vascular
    • 12.3.2. Lower Extremity
    • 12.3.3. Renal Vascular

13. Peripheral Supportive Guide Wire Market, by End User

  • 13.1. Ambulatory Surgical Centers
    • 13.1.1. Cardiovascular Centers
    • 13.1.2. Peripheral Centers
  • 13.2. Hospitals
  • 13.3. Specialty Clinics

14. Peripheral Supportive Guide Wire Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Peripheral Supportive Guide Wire Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Peripheral Supportive Guide Wire Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Peripheral Supportive Guide Wire Market

18. China Peripheral Supportive Guide Wire Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. AngioDynamics, Inc.
  • 19.7. Asahi Intecc Co., Ltd.
  • 19.8. B. Braun Melsungen AG
  • 19.9. Becton, Dickinson and Company
  • 19.10. BIOTRONIK SE & Co. KG
  • 19.11. Boston Scientific Corporation
  • 19.12. Cook Medical LLC
  • 19.13. Cordis Corporation
  • 19.14. Galt Medical Corp.
  • 19.15. Integer Holdings Corporation
  • 19.16. Medtronic plc
  • 19.17. Meril Life Sciences Private Limited
  • 19.18. Merit Medical Systems, Inc.
  • 19.19. MicroPort Scientific Corporation
  • 19.20. MicroVention, Inc.
  • 19.21. Stryker Corporation
  • 19.22. Teleflex Incorporated
  • 19.23. Terumo Corporation
  • 19.24. Vascular Solutions, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY HYDROPHILIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY HYDROPHILIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY HYDROPHILIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NON-HYDROPHILIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NON-HYDROPHILIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NON-HYDROPHILIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY HYDROPHILIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY HYDROPHILIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY HYDROPHILIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PTFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PTFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PTFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY ANGLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY ANGLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY ANGLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY J-TIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY J-TIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY J-TIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY STRAIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY STRAIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY STRAIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CORONARY ARTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CORONARY ARTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CORONARY ARTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY ANEURYSM COILING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY ANEURYSM COILING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY ANEURYSM COILING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY STROKE INTERVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY STROKE INTERVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY STROKE INTERVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CAROTID VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CAROTID VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CAROTID VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY LOWER EXTREMITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY LOWER EXTREMITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY LOWER EXTREMITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY RENAL VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY RENAL VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY RENAL VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 188. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 191. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 192. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 193. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 195. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 196. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 197. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. GCC PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 221. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 225. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 226. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 228. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 229. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 230. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. G7 PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 232. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 235. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 236. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 237. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 239. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 240. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 241. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. NATO PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY TIP CONFIGURATION, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA PERIPHERAL SUPPORTIVE GUIDE WIRE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)